Treatment of RA synovial fibroblasts with succinate in vitro increased production of basic fibroblast growth factor (bFGF) and cellular invasion, which could also contribute to the invasive pannus during disease (123). The gene discussed is FGF2; the disease is rheumatoid arthritis.